Motus GI (NASDAQ:MOTS) Price Target Cut to $1.50 by Analysts at HC Wainwright

Motus GI (NASDAQ:MOTS – Get Rating) had its target price decreased by HC Wainwright from $2.00 to $1.50 in a research note issued to investors on Monday morning, The Fly reports.

Other research analysts have also issued reports about the stock. Alliance Global Partners decreased their price target on shares of Motus GI from $1.75 to $1.40 in a research note on Wednesday, January 26th. Colliers Securities reaffirmed a buy rating on shares of Motus GI in a research note on Tuesday, March 22nd.

Shares of MOTS opened at $0.26 on Monday. The company has a 50-day simple moving average of $0.32 and a two-hundred day simple moving average of $0.42. The company has a debt-to-equity ratio of 1.18, a current ratio of 8.26 and a quick ratio of 8.09. The firm has a market capitalization of $14.39 million, a PE ratio of -0.67 and a beta of 2.40. Motus GI has a one year low of $0.24 and a one year high of $1.22.

Motus GI (NASDAQ:MOTS – Get Rating) last released its earnings results on Tuesday, March 29th. The company reported ($0.10) EPS for the quarter, meeting analysts’ consensus estimates of ($0.10). The company had revenue of $0.10 million during the quarter, compared to analysts’ expectations of $0.14 million. Motus GI had a negative return on equity of 138.62% and a negative net margin of 5,331.94%. During the same quarter last year, the business posted ($0.12) EPS. Analysts expect that Motus GI will post -0.46 EPS for the current fiscal year.

Institutional investors and hedge funds have recently bought and sold shares of the company. Virtu Financial LLC lifted its stake in shares of Motus GI by 654.5% in the fourth quarter. Virtu Financial LLC now owns 346,639 shares of the company’s stock worth $162,000 after buying an additional 300,696 shares in the last quarter. Citadel Advisors LLC lifted its position in Motus GI by 541.2% in the 4th quarter. Citadel Advisors LLC now owns 178,982 shares of the company’s stock valued at $84,000 after acquiring an additional 151,068 shares in the last quarter. Millennium Management LLC boosted its stake in Motus GI by 20.4% during the 3rd quarter. Millennium Management LLC now owns 118,652 shares of the company’s stock valued at $82,000 after purchasing an additional 20,110 shares during the last quarter. Morgan Stanley increased its holdings in shares of Motus GI by 41.7% in the 2nd quarter. Morgan Stanley now owns 51,000 shares of the company’s stock worth $53,000 after purchasing an additional 15,000 shares in the last quarter. Finally, Renaissance Technologies LLC purchased a new position in shares of Motus GI in the first quarter worth $26,000. 7.48% of the stock is owned by hedge funds and other institutional investors.

About Motus GI (Get Rating)

Motus GI Holdings, Inc, a medical technology company, develops Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedure. The company was incorporated in 2016 and is based in Fort Lauderdale, Florida.

Featured Articles